Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19

Detalles Bibliográficos
Autores principales: Kow, Chia Siang, Aldeyab, Mamoon, Hasan, Syed Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532950/
https://www.ncbi.nlm.nih.gov/pubmed/33011825
http://dx.doi.org/10.1007/s00228-020-03008-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532950/
https://www.ncbi.nlm.nih.gov/pubmed/33011825
http://dx.doi.org/10.1007/s00228-020-03008-6

Ejemplares similares